150 related articles for article (PubMed ID: 23362163)
1. Validation of the automated method VIENA: an accurate, precise, and robust measure of ventricular enlargement.
Vrenken H; Vos EK; van der Flier WM; Sluimer IC; Cover KS; Knol DL; Barkhof F
Hum Brain Mapp; 2014 Apr; 35(4):1101-10. PubMed ID: 23362163
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
[TBL] [Abstract][Full Text] [Related]
3. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.
Stevenson VL; Smith SM; Matthews PM; Miller DH; Thompson AJ
J Neurol; 2002 Feb; 249(2):171-7. PubMed ID: 11985382
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease.
Apostolova LG; Green AE; Babakchanian S; Hwang KS; Chou YY; Toga AW; Thompson PM
Alzheimer Dis Assoc Disord; 2012; 26(1):17-27. PubMed ID: 22343374
[TBL] [Abstract][Full Text] [Related]
5. The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis: A post-hoc analysis of the REFLEXION study.
Gentile G; Mattiesing RM; Brouwer I; van Schijndel RA; Uitdehaag BMJ; Twisk JWR; Kappos L; Freedman MS; Comi G; Jack D; Barkhof F; De Stefano N; Vrenken H; Battaglini M
Neuroimage Clin; 2023; 38():103397. PubMed ID: 37086648
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Mollenhauer B; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Neurobiol Aging; 2017 Jul; 55():78-90. PubMed ID: 28431288
[TBL] [Abstract][Full Text] [Related]
7. Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes.
Jakimovski D; Zivadinov R; Bergsland N; Ramasamy DP; Hagemeier J; Genovese AV; Hojnacki D; Weinstock-Guttman B; Dwyer MG
Neuroimage Clin; 2021; 29():102554. PubMed ID: 33472143
[TBL] [Abstract][Full Text] [Related]
8. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX.
Jasperse B; Valsasina P; Neacsu V; Knol DL; De Stefano N; Enzinger C; Smith SM; Ropele S; Korteweg T; Giorgio A; Anderson V; Polman CH; Filippi M; Miller DH; Rovaris M; Barkhof F; Vrenken H;
J Magn Reson Imaging; 2007 Oct; 26(4):881-5. PubMed ID: 17896359
[TBL] [Abstract][Full Text] [Related]
9. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.
Dwyer MG; Silva D; Bergsland N; Horakova D; Ramasamy D; Durfee J; Vaneckova M; Havrdova E; Zivadinov R
Neuroimage Clin; 2017; 15():769-779. PubMed ID: 28706852
[TBL] [Abstract][Full Text] [Related]
10. Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRI.
Amiri H; Brouwer I; Kuijer JPA; de Munck JC; Barkhof F; Vrenken H
Neuroimage Clin; 2019; 21():101667. PubMed ID: 30665101
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images.
Martola J; Bergström J; Fredrikson S; Stawiarz L; Hillert J; Zhang Y; Flodmark O; Lilja A; Ekbom A; Aspelin P; Wiberg MK
Neuroradiology; 2010 Feb; 52(2):109-17. PubMed ID: 19774369
[TBL] [Abstract][Full Text] [Related]
12. 2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis.
Pontillo G; Cocozza S; Di Stasi M; Carotenuto A; Paolella C; Cipullo MB; Perillo T; Vola EA; Russo C; Masullo M; Moccia M; Lanzillo R; Tedeschi E; Elefante A; Brescia Morra V; Brunetti A; Quarantelli M; Petracca M
Eur Radiol; 2020 Jul; 30(7):3813-3822. PubMed ID: 32100089
[TBL] [Abstract][Full Text] [Related]
13. Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI.
Preboske GM; Gunter JL; Ward CP; Jack CR
Neuroimage; 2006 May; 30(4):1196-202. PubMed ID: 16380273
[TBL] [Abstract][Full Text] [Related]
14. Rate of ventricular enlargement in multiple sclerosis: a nine-year magnetic resonance imaging follow-up study.
Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergstrom J; Flodmark O; Aspelin P; Kristoffersen Wiberg M
Acta Radiol; 2008 Jun; 49(5):570-9. PubMed ID: 18568545
[TBL] [Abstract][Full Text] [Related]
15. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.
Nestor SM; Rupsingh R; Borrie M; Smith M; Accomazzi V; Wells JL; Fogarty J; Bartha R;
Brain; 2008 Sep; 131(Pt 9):2443-54. PubMed ID: 18669512
[TBL] [Abstract][Full Text] [Related]
16. Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
Nakamura K; Brown RA; Narayanan S; Collins DL; Arnold DL;
Neuroimage; 2015 Sep; 118():126-32. PubMed ID: 26049148
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.
Zivadinov R; Bergsland N; Korn JR; Dwyer MG; Khan N; Medin J; Price JC; Weinstock-Guttman B; Silva D;
AJNR Am J Neuroradiol; 2018 Feb; 39(2):289-295. PubMed ID: 29170269
[TBL] [Abstract][Full Text] [Related]
18. Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia.
Bigler ED; Neeley ES; Miller MJ; Tate DF; Rice SA; Cleavinger H; Wolfson L; Tschanz J; Welsh-Bohmer K
J Int Neuropsychol Soc; 2004 May; 10(3):442-52. PubMed ID: 15147601
[TBL] [Abstract][Full Text] [Related]
19. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
Tang X; Holland D; Dale AM; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jun; 36(6):2093-117. PubMed ID: 25644981
[TBL] [Abstract][Full Text] [Related]
20. Consistent multi-time-point brain atrophy estimation from the boundary shift integral.
Leung KK; Ridgway GR; Ourselin S; Fox NC;
Neuroimage; 2012 Feb; 59(4):3995-4005. PubMed ID: 22056457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
